A TRIPS Waiver for COVID-19 Medicines is Harmful and Unnecessary

TRIPS Waiver for COVID-19

A TRIPS Waiver for COVID-19 Medicines is Harmful and Unnecessary 2023 America‚Äôs biopharmaceutical industry relies on strong intellectual property (IP) protections to incentivize the research, development and manufacturing of cutting-edge technologies. Without strong IP protections, modern medical innovation would be significantly stymied. What is TRIPS? The World Trade Organization (WTO) Agreement on Trade-Related Aspects of … Read more